Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Omkar Pharmachem Share Price
6.25+0.00 (+0.00%)
-77.94% past 1 Year
News
Venezuela Oil Output Stays Low Despite Planned Investment Push
Commodity
Venezuela Oil Revival Boosts El Tigre Business Activity
Commodity
Asian Markets Mixed As Kospi Gains While Nikkei And ASX 200 Decline
Broader Market
European Stock Futures Decline Amid Renewed Global Market Caution
Broader Market
Democrat Jon Ossoff Wins Georgia Senate Race Boosting Democratic Senate Prospects
Broader Market
US Stock Futures Edge Lower As Investors Assess Global Market Direction
Broader Market
Stocks To Watch Include Quarterly Results And Camlin Fine Rights Issue
Equity
Camlin Fine Sciences Reports Wider Loss Despite Revenue Growth in Second Quarter
Equity
Neuland Laboratories Reports Sharp Decline In Second Quarter Earnings
Equity
Harsha Engineers Reports Strong Q2 Growth In Profit Revenue And EBITDA
Equity
Medanta Reports Strong Q2 Growth With Higher Profit Revenue And EBITDA
Equity
Seamec Reports Strong Q2 Profit Growth on Higher Revenue
Equity
Savita Oil Technologies Reports Strong Second Quarter Profit Growth
Equity
Datamatics Reports Strong Q2 Growth With Higher Profit Revenue And Margins
Equity
Pokarna Reports Strong Second Quarter Profit And Revenue Growth
Equity
NSE Reports Strong Year On Year Growth In Q2 Revenue And EBITDA
Equity
JG Chemicals Reports Strong Q2 Growth With Higher Revenue Profit And EBITDA
Equity
Servotech Reports Strong Growth In Q2 Consolidated Profit Revenue And EBITDA
Equity
Dalmia Bharat Sugar Reports Strong Q2 Profit And Operating Performance Growth
Equity
Lloyds Metals Reports Strong Second Quarter Profit and Revenue Growth
Equity